WINDTREE THERAPEUTICS INC /DE/ Line of Credit Facility, Maximum Borrowing Capacity
WINDTREE THERAPEUTICS INC /DE/ (WINT) had Line of Credit Facility, Maximum Borrowing Capacity of $30.00 million as of 2016-12-31, per its 10-K filed 2017-03-31.
Discontinued › Notes › Debt
us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity · last filed 2017-03-31
- 2016-12-31: Line of Credit Facility, Maximum Borrowing Capacity $30.00M.
- 2015-12-31: Line of Credit Facility, Maximum Borrowing Capacity $30.00M.
- 2014-12-31: Line of Credit Facility, Maximum Borrowing Capacity $30.00M.
- 2014-09-30: Line of Credit Facility, Maximum Borrowing Capacity $30.00M.
| Period end | Line of Credit Facility, Maximum Borrowing Capacity |
|---|---|
| 2016-12-31 | $30.00M 10-K · filed 2017-03-31 |
| 2015-12-31 | $30.00M 10-K · filed 2016-03-29 |
| 2014-12-31 | $30.00M 10-K · filed 2015-03-16 |
| 2014-09-30 | $30.00M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $30.00M 10-Q · filed 2014-08-07 |
| 2014-03-31 | $30.00M 10-Q · filed 2014-05-12 |
| 2013-12-31 | $30.00M 10-K · filed 2014-03-17 |
| 2013-09-30 | $30.00M 10-Q · filed 2013-11-12 |
| 2013-06-30 | $30.00M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $30.00M 10-Q · filed 2013-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |
| Silexion Therapeutics Corp (SLXN) | $0.001B | ||
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| CERO THERAPEUTICS HOLDINGS, INC. (CERO) | United States | $0.007B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |